These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19896304)

  • 1. Twenty years after cystic fibrosis gene identification: Where are we and what are we up to?
    Edelman A; Fritsch J; Ollero M
    Pathol Biol (Paris); 2011 Jun; 59(3):131-3. PubMed ID: 19896304
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete map of cystic fibrosis mutation DF508 frequencies in Western Europe and correlation between mutation frequencies and incidence of disease.
    Lucotte G; Hazout S; De Braekeleer M
    Hum Biol; 1995 Oct; 67(5):797-803. PubMed ID: 8543293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G542X as a probable Phoenician cystic fibrosis mutation.
    Loirat F; Hazout S; Lucotte G
    Hum Biol; 1997 Jun; 69(3):419-25. PubMed ID: 9164051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
    Du K; Sharma M; Lukacs GL
    Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystic fibrosis: the CFTR gene, its mutations, the genetic counseling].
    Goossens M; Ghanem N; Girodon E; Costes B; Fanen P
    Rev Pneumol Clin; 1995; 51(3):130-6. PubMed ID: 7569574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protein repair therapy in cystic fibrosis].
    Clément A; Tamalet A; Fauroux B; Epaud R
    Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new frameshift mutation 460delG in exon 4 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Wagner K; Schneditz P; Rosenkranz W
    Hum Mutat; 1996; 7(2):183. PubMed ID: 8829644
    [No Abstract]   [Full Text] [Related]  

  • 8. [The type and frequency of mutations in CFTR gene occurrence in patients with cystic fibrosis in Poland--implication of results obtained from genetic counseling and diagnostic screening].
    Bal J; Maciejko D; Mazurczak T
    Pediatr Pol; 1995 Aug; 70(8):627-32. PubMed ID: 8668362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An abnormal distribution of delta F508 genotypes in cystic fibrosis patient registries.
    Feingold J; Guilloud-Bataille M; De Crozes D
    Ann Genet; 1998; 41(1):31-3. PubMed ID: 9599649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel mutation (525del T) in exon 4 of the CFTR gene in a patient with cystic fibrosis.
    Kusic J; Radojkovic D; Cuppens H; Jaspers M; Tomic J; Savic A
    Hum Mutat; 1999 Oct; 14(4):357. PubMed ID: 10502789
    [No Abstract]   [Full Text] [Related]  

  • 11. Age of the delta F508 cystic fibrosis mutation.
    Kaplan NL; Lewis PO; Weir BS
    Nat Genet; 1994 Nov; 8(3):216-8. PubMed ID: 7533028
    [No Abstract]   [Full Text] [Related]  

  • 12. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.
    Gelman MS; Kopito RR
    Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular repair of a defective CFTR protein in cystic fibrosis.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2011 Apr; 35(4):254-6. PubMed ID: 21349786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of cystic fibrosis.
    Shrimpton AE
    Expert Rev Mol Diagn; 2002 May; 2(3):240-56. PubMed ID: 12050863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis: gene therapy or preventive gene transfer?
    Drittanti L; Masciovecchio MV; Gabbarini J; Vega M
    Gene Ther; 1997 Oct; 4(10):1001-3. PubMed ID: 9415304
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype.
    Norek A; Stremska M; Sobczyńska-Tomaszewska A; Wertheim-Tysarowska K; Dmeńska H; Jurek M
    J Pediatr; 2011 Aug; 159(2):343-6.e1. PubMed ID: 21663921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of 9 common mutations in the CFTR gene in Slovak cystic fibrosis patients.
    Kádasi L; Poláková H; Zatková A; Kayserová H
    Gene Geogr; 1997 Apr; 11(1):51-6. PubMed ID: 9615214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro CFTR folding assays.
    Stidham RD; Wigley WC; Thomas PJ
    Methods Mol Med; 2002; 70():311-22. PubMed ID: 11917534
    [No Abstract]   [Full Text] [Related]  

  • 19. What happens to deltaF508 in vivo?
    Drumm M
    J Clin Invest; 1999 May; 103(10):1369-70. PubMed ID: 10330418
    [No Abstract]   [Full Text] [Related]  

  • 20. Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2009 Oct; 48(41):9882-90. PubMed ID: 19761259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.